Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Breaking tolerance in a mouse model of multiple myeloma by chemoimmunotherapy.

Sharabi A, Ghera NH.

Adv Cancer Res. 2010;107:1-37. doi: 10.1016/S0065-230X(10)07001-6. Review.

PMID:
20399959
2.

Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model.

Sharabi A, Laronne-Bar-On A, Meshorer A, Haran-Ghera N.

Cancer Prev Res (Phila). 2010 Oct;3(10):1265-76. doi: 10.1158/1940-6207.CAPR-10-0138. Epub 2010 Aug 18.

3.
4.

CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.

Siepmann K, Biester S, Plsková J, Muckersie E, Duncan L, Forrester JV.

Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):221-9.

PMID:
16741709
5.

Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.

Sharabi A, Haran-Ghera N.

Bone Marrow Res. 2011;2011:269519. doi: 10.1155/2011/269519. Epub 2011 Apr 6.

6.
7.

Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.

Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S.

J Immunol. 1999 May 1;162(9):5317-26.

8.

Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide.

Motoyoshi Y, Kaminoda K, Saitoh O, Hamasaki K, Nakao K, Ishii N, Nagayama Y, Eguchi K.

Oncol Rep. 2006 Jul;16(1):141-6.

PMID:
16786137
9.

The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.

Javeed A, Zhang B, Qu Y, Zhang A, Sun C, Zhang L, Liu J, Zeng C, Zhao Y.

Transpl Immunol. 2009 Mar;20(4):253-60. doi: 10.1016/j.trim.2008.12.001. Epub 2009 Jan 13.

PMID:
19146957
10.

Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites.

Chaput N, Darrasse-Jèze G, Bergot AS, Cordier C, Ngo-Abdalla S, Klatzmann D, Azogui O.

J Immunol. 2007 Oct 15;179(8):4969-78.

11.

Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity.

Saxton ML, Longo DL, Wetzel HE, Tribble H, Alvord WG, Kwak LW, Leonard AS, Ullmann CD, Curti BD, Ochoa AC.

Blood. 1997 Apr 1;89(7):2529-36.

14.

Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model.

Banissi C, Ghiringhelli F, Chen L, Carpentier AF.

Cancer Immunol Immunother. 2009 Oct;58(10):1627-34. doi: 10.1007/s00262-009-0671-1. Epub 2009 Feb 17.

PMID:
19221744
15.

Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.

Ma A, Qi S, Wang Z, Massicotte E, Dupuis M, Daloze P, Chen H.

Int Immunopharmacol. 2009 May;9(5):553-63. doi: 10.1016/j.intimp.2009.01.033. Epub 2009 Feb 8.

PMID:
19539558
16.

Alloantigen specific T regulatory cells in transplant tolerance.

Hall BM, Tran G, Hodgkinson SJ.

Int Immunopharmacol. 2009 May;9(5):570-4. doi: 10.1016/j.intimp.2009.01.016. Epub 2009 Jan 29. Review.

PMID:
19539571
18.

Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine.

Liu JY, Wu Y, Zhang XS, Yang JL, Li HL, Mao YQ, Wang Y, Cheng X, Li YQ, Xia JC, Masucci M, Zeng YX.

Cancer Immunol Immunother. 2007 Oct;56(10):1597-604. Epub 2007 Apr 18.

PMID:
17440723
19.

CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.

Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.

Haematologica. 2008 Mar;93(3):423-30. doi: 10.3324/haematol.11897. Epub 2008 Feb 20.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk